NLC VIRAL DEFENCE LLC – Trademark Portfolio

Entity Type: 16

NLC VIRAL DEFENCE LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TOLLOVID and TODOS MEDICAL. The owner is based in BROOKLYN, NY.

314 BEDFORD AVE, SUITE 2A

BROOKLYN, NY 11211

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

NLC VIRAL DEFENCE LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does NLC VIRAL DEFENCE LLC have?

NLC VIRAL DEFENCE LLC has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.

What trademark classes does NLC VIRAL DEFENCE LLC file in?

NLC VIRAL DEFENCE LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are NLC VIRAL DEFENCE LLC's most well-known trademarks?

NLC VIRAL DEFENCE LLC's registered trademark portfolio includes well-known marks such as TOLLOVID and TODOS MEDICAL. These are among 2 currently registered trademarks in the portfolio.

What is NLC VIRAL DEFENCE LLC's trademark registration success rate?

NLC VIRAL DEFENCE LLC has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.